Nasdaq-Listed Blue Gold Limited (BGL) Announces Updated Analyst Price Target of Up to $20 — Neutral
BGL GlobeNewsWire — December 19, 2025The revised valuation reflects growing institutional interest in gold-backed financial solutions and integrated digital infrastructure. Image by Blue Gold Limited NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL), a vertically integrated gold fintech company , today announced that an updated independent analyst report has set a revised price target of up to $20 per share.
Tecnoglass Inc. (TGLS) Shareholder/Analyst Call Prepared Remarks Transcript — Neutral
TGLS Seeking Alpha — December 19, 2025Tecnoglass Inc. (TGLS) Shareholder/Analyst Call Prepared Remarks Transcript
CRWV Stock Crashes 49% in 3 Months: Buy the Dip or Hold Back for Now? — Negative
CRWV Zacks Investment Research — December 19, 2025CoreWeave has plunged nearly 50% from its highs as supply-chain delays, heavy CapEx and leverage hit shares despite a massive $55.6B backlog.
E-Commerce Powers Holiday Sales: 4 Stocks With Upside for 2026 — Positive
AMZN EXPE FVRR GCT Zacks Investment Research — December 19, 2025Amazon stands out as e-commerce drives a record 2025 holiday season, with Cyber Monday at $14.25 billion and online sales projected at $253.4 billion.
Meta is reportedly working on new multimedia model with H1 2026 release date in mind — Positive
META TechCrunch — December 19, 2025It's all hands on deck at Meta, as the company develops new AI models under its superintelligence lab led by Scale AI co-founder, Alexandr Wang. The company is now working on an image and video model codenamed “Mango” along with a new text-based model internally known as “Avocado,” The Wall Street Journal reported.
Meta is developing a new image and video model for a 2026 release, report says — Positive
META TechCrunch — December 19, 2025It's all hands on deck at Meta, as the company develops new AI models under its superintelligence lab led by Scale AI co-founder, Alexandr Wang. The company is now working on an image and video model codenamed “Mango” along with a new text-based model internally known as “Avocado,” The Wall Street Journal reported.
Paychex's higher quarterly expenses overshadow annual earnings forecast raise — Negative
PAYX Reuters — December 19, 2025Payroll services provider Paychex reported higher expenses for the second quarter on Friday, taking the shine off its raise in annual adjusted earnings growth forecast.
Carnival makes splash with dividend return and single NYSE-listed share plan — Positive
CCL Proactive Investors — December 19, 2025Carnival PLC & Corporation made a splash with its final results for 2025 as it reinstated its dividend, forecast further earnings growth and proposed unifying its dual-listed structure into a single New York-listed entity. Shares in the FTSE 100-listed cruise operator sailed 16.7% higher in London to 2,315p, the highest since the first Covid lockdown of 2020, while rising 9.7% to $31.08 on the NYSE.
GM Financial to Release Fourth Quarter and Calendar Year 2025 Operating Results — Neutral
GM Business Wire — December 19, 2025FORT WORTH, Texas--(BUSINESS WIRE)--GENERAL MOTORS FINANCIAL COMPANY, INC. (“GM Financial” or the “Company”) will release its fourth quarter and calendar year 2025 operating results on Tuesday, January 27, 2026. The press release and earnings presentation for fixed income investors will be posted to the Investor Relations section of the Company's website at www.gmfinancial.com. Questions on the materials should be directed to GM Financial's Investor Relations Department. The company's subsequen.
Best Momentum Stocks to Buy for Dec. 19 — Positive
HNRG IVZ MDB Zacks Investment Research — December 19, 2025MDB, HNRG and IVZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 19, 2025.
Lamb Weston (LW) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
LW Zacks Investment Research — December 19, 2025Although the revenue and EPS for Lamb Weston (LW) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
D.R. Horton: Strong Fed Upside Potential From 2026 Onwards (Upgrade) — Positive
DHI Seeking Alpha — December 19, 2025D.R. Horton's vertically integrated model, aggressive sales incentives, and improved consumer affordability underpin the upgraded Buy rating, despite macro headwinds. Recent Fed rate cuts, higher net sales orders, and robust operational scale position DHI for continued profitable operations into FY2026. While profit margins have normalized nearer to pre-COVID levels, the company's valuation and consensus forward estimates offer an attractive risk/reward profile.
Payactiv Earned Wage Access Solution Now Available on SAP® Store — Neutral
SAP Business Wire — December 19, 2025SILICON VALLEY, Calif.--(BUSINESS WIRE)--Payactiv is now officially listed on the SAP® Store for SAP SuccessFactors HCM customers.
Cboe Congratulates Michael Selig on Confirmation as CFTC Chairman — Neutral
CBOE PRNewsWire — December 19, 2025CHICAGO , Dec. 19, 2025 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today issued the following statement in response to the Senate confirmation of Michael Selig as Chairman of the Commodity Futures Trading Commission (CFTC): "On behalf of Cboe, we congratulate Michael Selig on his confirmation as Chairman of the CFTC," said Craig Donohue, CEO of Cboe Global Markets. "He brings deep experience across financial markets and a thoughtful, balanced approach to regulation that will be essential as the derivatives markets continue to evolve at a rapid pace.
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman — Neutral
TLSA GlobeNewsWire — December 19, 2025BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that its Executive Chairman and Founder, Mr. Gabriele Cerrone, has purchased 97,687 common shares, bringing his total holding to 43,374,830 common shares, which is 36.08% of issued share capital.
CyberArk Named a Leader in IDC MarketScape: Worldwide Integrated Solutions for Identity Security 2025 — Neutral
CYBR Business Wire — December 19, 2025NEWTON, Mass. & PETACH TIKVA, Israel--(BUSINESS WIRE)--CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced that it has been recognized as a Leader in the IDC MarketScape: Worldwide Integrated Solutions for Identity Security 2025 Vendor Assessment. CyberArk extends dynamic privilege controls across all identity types with its unified platform, enabling organizations to improve efficiencies and streamline security operations. This IDC MarketScape report notes, “More c.
Shareholder Alert: The Ademi Firm investigates whether Amicus Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders — Neutral
FOLD PRNewsWire — December 19, 2025MILWAUKEE , Dec. 19, 2025 /PRNewswire/ -- The Ademi Firm is investigating Amicus (Nasdaq: FOLD) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with BioMarin. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross — Positive
COO Zacks Investment Research — December 19, 2025The Cooper Companies, Inc. (COO) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, COO's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Wall Street Analysts Think Cousins Properties (CUZ) Could Surge 25.75%: Read This Before Placing a Bet — Positive
CUZ Zacks Investment Research — December 19, 2025The consensus price target hints at a 25.8% upside potential for Cousins Properties (CUZ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 27.31% Upside in Interactive Brokers (IBKR): Can the Stock Really Move This High? — Positive
IBKR Zacks Investment Research — December 19, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 27.3% in Interactive Brokers (IBKR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.